1️⃣ The Governing Structure: ABIM
In the U.S., specialty certification is governed by:
American Board of Internal Medicine (ABIM)
Under the umbrella of the American Board of Medical Specialties (ABMS)
Hepatology is not an independent primary subspecialty.
It is officially: “Transplant Hepatology” — a subspecialty of Gastroenterology
That structure is the key to what follows.
2️⃣ When Did This Structure Form?
1930s–1960s: Internal Medicine Subspecialties Form
- Cardiology, GI, Pulmonary, etc. became subspecialties of Internal Medicine.
- Liver disease was managed inside GI because:
- Cirrhosis complications overlap with portal hypertension, varices, endoscopy.
- Training programs were hospital-based within medicine divisions.
- Hepatology was small and transplant did not yet exist.
There was no separate hepatology pathway.
1980s–1990s: Liver Transplant Era Expands
With liver transplantation growth:
- Liver disease became more specialized.
- Academic hepatology divisions emerged.
- Fellowship training in advanced liver disease became structured.
But instead of creating an independent “Hepatology” board,
the ABIM structured it as: Advanced training after GI fellowship.
2006: Formal Recognition
The ABIM formally recognized Transplant Hepatology as a subspecialty of Gastroenterology.
Requirements:
- 3 years Internal Medicine residency
- 3 years Gastroenterology fellowship
- 1 additional year Transplant Hepatology
So that pathway became institutionalized.
3️⃣ Why GI First?
It wasn’t because hepatology must be GI.
It was because:
A) Administrative Simplicity
GI already existed as an ABIM-recognized subspecialty.
Hepatology programs lived inside GI divisions.
So ABIM housed it there.
B) Historical Practice Patterns
Traditionally:
- Varices → endoscopy (GI skill)
- Portal hypertension → GI
- GI bleeding → GI
- Many liver patients required endoscopic management
So clinically, there was overlap.
C) Political & Academic Power
GI was:
- Larger
- More established
- More funded
- More represented in academic leadership
Hepatology did not have independent institutional leverage.
4️⃣ Was There Debate?
Yes.
There have long been discussions about:
- Creating a standalone hepatology pathway (like cardiology)
- Shortening GI requirements for liver-focused physicians
- Allowing Internal Medicine → Hepatology directly
But ABIM has kept the current structure.
5️⃣ Contrast With Other Countries
In Europe and parts of Asia:
- Hepatology can be more independent.
- GI training may not be mandatory in the same way.
- Some countries allow Internal Medicine → Hepatology directly.
The U.S. model is more rigid.
6️⃣ Net Net
The GI-first structure:
- Might artificially constrain the hepatology workforce supply
- Tends to filter liver diagnosis/care through GI procedural training
- Likely slows scaling of metabolic liver expertise nationally.
And in 2026 — with MASH a metabolic disease — the GI-first pipeline looks increasingly ready for reconsideration.
Indeed, one could argue that the medical-academic training model was built for portal hypertension and transplant, not population-level metabolic liver disease.